BlackRock, Inc. 13D and 13G filings for AbbVie Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-25 4:59 pm Purchase | 2023-12-31 | 13G | AbbVie Inc. ABBV | BlackRock Inc. BLK | 143,180,060 8.100% | 4,477,302 (+3.23%) | Filing |
| 2023-02-15 5:45 pm Purchase | 2022-12-31 | 13G | AbbVie Inc. ABBV | BlackRock Inc. BLK | 138,702,758 7.800% | 10,505,203 (+8.19%) | Filing |
| 2022-02-03 4:29 pm Purchase | 2021-12-31 | 13G | AbbVie Inc. ABBV | BlackRock Inc. BLK | 128,197,555 7.300% | 3,774,071 (+3.03%) | Filing |
| 2021-01-28 6:11 pm Purchase | 2020-12-31 | 13G | AbbVie Inc. ABBV | BlackRock Inc. BLK | 124,423,484 7.000% | 25,829,674 (+26.20%) | Filing |